Possible mild effects : local injection site soreness, slight flushing Rare : nausea, dizziness, allergic reaction Contraindications : hypersensitivity to any component
By contrast, decreased TXNIP expression is associated with enhanced migration, invasion and metastatic potential in colorectal cancer, cervical cancer, melanoma and pancreatic cancer (56)
What the trials show Key trial programs anchor the evidence: STEP evaluated semaglutide for weight management ( The New England Journal of Medicine , 2021), SURMOUNT evaluated tirzepatide for weight management (NEJM 2022), and SURMOUNT-OSA evaluated tirzepatide for obstructive sleep apnea (NEJM 2024)
These findings are important as they may broaden the indications for these medications and benefit a larger patient population, added Mir Ali, MD, a general surgeon and bariatric surgeon as well as the medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA
Can You Take Both Together on GLP-1 Therapy
Parkinsons disease (PD) is influenced by chronic inflammation
